The beverage green tea
(Simplified Chinese: Traditional Chinese: Pinyin:
lǜchá) is
a "true" tea (i.e., Camellia sinensis) that
has undergone minimal
oxidation during processing.
Green tea is popular in China,
Korea, Uzbekistan, Kyrgyzstan, Kazakhstan, Japan,
Pakistan, Taiwan, Hong Kong, Morocco, and the Middle
East. Recently, it has become more widespread in the
West, where traditionally
black tea
is consumed.
History
There is archaeological evidence that suggests
that tea has been consumed for almost 5000 years,
with India and China being two of the first
countries to cultivate it. Green tea has been used
as traditional medicine in areas such as India,
China, Japan and Thailand to help everything from
controlling bleeding and helping heal wounds to
regulating body temperature, blood sugar and
promoting digestion.
The Kissa Yojoki (Book of Tea,
written by Zen priest Eisai in 1191, describes how
drinking green tea can have a positive effect on the
five vital organs, especially the heart. The book
discusses tea's medicinal qualities, which include
easing the effects of alcohol, acting as a
stimulant, curing blotchiness, quenching thirst,
eliminating indigestion, curing beriberi disease,
preventing fatigue, and improving urinary and brain
function. Part One also explains the shapes of tea
plants, tea flowers, and tea leaves, and covers how
to grow tea plants and process tea leaves. In Part
Two, the book discusses the specific dosage and
method required for individual physical ailments.
United States Food and
Drug Administration (FDA)
The article Tea: A Story of Serendipity
appeared in the March 1996 issue of FDA Consumer
Magazine and looked at the potential benefits of
green tea. At that time they had not done any
reviews of the potential benefits of green tea and
were waiting to do it until health claims were
filed. They have since denied two petitions to make
qualified health claims as to the health benefits of
green tea.
On June 30, 2005, in response to "Green Tea and
Reduced Risk of Cancer Health Claim", they stated:
"FDA concludes that there is no credible evidence to
support qualified health claims for green tea
consumption and a reduced risk of gastric, lung,
colon/rectal, esophageal, pancreatic, ovarian, and
combined cancers. Thus, FDA is denying these claims.
However, FDA concludes that there is very limited
credible evidence for qualified health claims
specifically for green tea and breast cancer and for
green tea and prostate cancer, provided that the
qualified claims are appropriately worded so as to
not mislead consumers."
On May 9, 2006, in response to "Green Tea and
Reduced Risk of Cardiovascular Disease", they
concluded "there is no credible evidence to support
qualified health claims for green tea or green tea
extract and a reduction of a number of risk factors
associated with CVD."
However in October 2006, the FDA approved an
ointment based on green tea. New Drug Application (NDA)
number N021902, for kunecatechins ointment 15%
(proprietary name Veregen) was approved on October
31, 2006, and added to the "Prescription Drug
Product List" in October 2006. Kunecatechins
ointment is indicated for the topical treatment of
external genital and perianal warts.
Scientific studies
A 2006 study published in the September 13 issue
of the Journal of the American Medical Association
concluded "Green tea consumption is associated with
reduced mortality due to all causes and due to
cardiovascular disease but not with reduced
mortality due to cancer." The study, conducted by
the Tohoku University School of Public Policy in
Japan, followed 40,530 Japanese adults, ages 40-79,
with no history of stroke, coronary heart disease,
or cancer at baseline beginning in 1994. The study
followed all participants for up to 11 years for
death from all causes and for up to 7 years for
death from a specific cause. Participants who
consumed 5 or more cups of tea per day had a 16
percent lower risk of all-cause mortality and a 26
percent lower risk of cardiovascular disease than
participants who consumed less than one cup of tea
per day. The study also states, "If green tea does
protect humans against CVD or cancer, it is expected
that consumption of this beverage would
substantially contribute to the prolonging of life
expectancy, given that CVD and cancer are the two
leading causes of death worldwide."
A study published in the February 2006 edition of
the American Journal of Clinical Nutrition concluded
"A higher consumption of green tea is associated
with a lower prevalence of cognitive impairment in
humans."
In May 2006, researchers at Yale University
School of Medicine weighed in on the issue with a
review article that looked at more than 100 studies
on the health benefits of green tea. They pointed to
what they called an "Asian paradox," which refers to
lower rates of heart disease and cancer in Asia
despite high rates of cigarette smoking. They
theorized that the 1.2 liters of green tea that is
consumed by many Asians each day provides high
levels of polyphenols and other antioxidants. These
compounds may work in several ways to improve
cardiovascular health, including preventing blood
platelets from sticking together (This anticoagulant
effect is the reason doctors warn surgical patients
to avoid green tea prior to procedures that rely on
a patient's clotting ability) and improving
cholesterol levels, said the researchers, whose
study appeared in the May issue of the Journal of
the American College of Surgeons. Specifically,
green tea may prevent the oxidation of LDL
cholesterol (the "bad" type), which, in turn, can
reduce the buildup of plaque in arteries, the
researchers wrote.
A study published in the August 22, 2006 edition
of Biological Psychology looked at the modification
of the stress response via L-Theanine, a chemical
found in green tea. It "suggested that the oral
intake of L-Theanine could cause anti-stress effects
via the inhibition of cortical neuron excitation."
In a double-blind, randomized, placebo-controlled
trial done by Division of Cardiovascular Medicine,
Vanderbilt University Medical Center, Nashville,
Tennessee, 240 adults were given either theaflavin-enriched
green tea extract in form of 375mg capsule daily or
a placebo. After 12 weeks, patients in the tea
extract group had significantly less low-density
lipoprotein cholesterol (LDL-C) and total
cholesterol (16.4% and 11.3% lower than baseline,
p<0.01) than the placebo group. The author concluded
that theaflavin-enriched green tea extract can be
used together with other dietary approaches to
reduce LDL-C.
A study published in the January, 2005 edition of
the American Journal of Clinical Nutrition concluded
"Daily consumption of tea containing 690 mg
catechins for 12 wk reduced body fat, which suggests
that the ingestion of catechins might be useful in
the prevention and improvement of lifestyle-related
diseases, mainly obesity."
Antioxidants in green tea may prevent and reduce
the severity of rheumatoid arthritis, according to a
Case Western Reserve University School of Medicine
study published in the April 13 2005 issue of the
Proceedings of the National Academy of Sciences. The
study examined the effects of green tea polyphenols
on collagen-induced arthritis in mice, which is
similar to rheumatoid arthritis in humans. In each
of three different study groups, the mice given the
green tea polyphenols were significantly less likely
to develop arthritis. Of the 18 mice that received
the green tea, only eight (44 percent) developed
arthritis. Among the 18 mice that did not receive
the green tea, all but one (94 percent) developed
arthritis. In addition, researchers noted that the
eight arthritic mice that received the green tea
polyphenols developed less severe forms of
arthritis.
A German study found that an extract of green tea
and hot water (filtered), applied externally to the
skin for 10 minutes, three times a day could help
people with skin damaged from radiation therapy
(after 16-22 days).
A study published in the December 1999 American
Journal of Clinical Nutrition found that "Green tea
has thermogenic properties and promotes fat
oxidation beyond that explained by its caffeine
content per se. The green tea extract may play a
role in the control of body composition via
sympathetic activation of thermogenesis, fat
oxidation, or both."
In lab tests, EGCG, found in green tea, was found
to prevent HIV from attacking T-Cells. However, it
is not known if this has any effect on humans yet.
A study in the August, 2003 issue of a new
potential application of Cellular and Molecular Life
Sciences found that "a new potential application of
(–)-epigallocatechin-3-gallate [a component of green
tea] in prevention or treatment of inflammatory
processes is suggested"